Rock Creek Group’s P3 Health Partners PIII Stock Holding History

Rock Creek Group’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,523	Closed	-$406K	–	207
2021 Q4	$406K	Buy	+1,523	New	+$727K	0.06%	102

Other funds holding PIII

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIP

Nicholas Investment Partners Rancho Santa Fe, California $1.78B AUM 114.03% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rock Creek Group's PIII Position: Q1 2022 in Review

Rock Creek Group sold out of P3 Health Partners (PIII) in Q1 2022, closing a stake of 1,523 shares — an estimated $406K sold.

Rock Creek Group first reported a position in PIII in Q4 2021 and held it in 1 quarter. The position peaked at $406K in Q4 2021. 35 funds tracked by Wall St. Rank hold PIII as of Q1 2022.

Rock Creek Group reported no remaining P3 Health Partners position as of Q1 2022 after selling out during the quarter.
Rock Creek Group sold 1,523 P3 Health Partners shares in Q1 2022, an estimated $406K.
Rock Creek Group first reported a position in P3 Health Partners in Q4 2021 and held it in 1 quarter.
Rock Creek Group's P3 Health Partners position peaked at $406K in Q4 2021.
35 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2022.

Based on Rock Creek Group's 13F filing for Q1 2022, filed 11 May 2022.